Enepret Incorporated — Department of Health and Human Services SBIR Phase II: 106
Enepret Incorporated — SBIR Phase II award from Department of Health and Human Services.
- Amount
- $2,996,311
- Agency
- Department of Health and Human Services · National Institutes of Health
- Program / Phase
- SBIR · Phase II
- Topic
- 106
- Solicitation
- PHS-2022-1
- NAICS
- —
- Place of performance
- KY
- Period
- —
Description
Squalene-based oil-in-water emulsions, such as MF59, have been shown to demonstrate adjuvant activity in a variety of vaccine settings, including seasonal influenza vaccine. The awardee seeks to develop a mimic of MF59 using squalene that has been sustainably synthesized by yeast cultures. This adjuvant will be tested in preclinical studies and advanced toward large production capacity.